poractant alfa
poractant alfa is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Curosurf. Available dosage form: suspension.
Drug Details
- Generic Name
- poractant alfa
- Brand Names
- Curosurf
- Application Number
- BLA020744
- Sponsor
- Chiesi USA, Inc.
- NDC Codes
- 1
- Dosage Forms
- SUSPENSION
- Routes
- ENDOTRACHEAL
- Active Ingredients
- PORACTANT ALFA
Indications and Usage
1 INDICATIONS AND USAGE CUROSURF ® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants. CUROSURF reduces mortality and pneumothoraces associated with RDS. CUROSURF is a surfactant indicated for the rescue treatment, including the reduction of mortality and pneumothoraces, of Respiratory Distress Syndrome (RDS) in premature infants. ( 1 )